Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases

Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases

US Patent 9795561 · Granted Oct 24, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Destination address rewriting to block peer-to-peer communications2017
Destination address control to limit unauthorized communications2016
Systems and methods for queue management in packet-switched networks2012
Systems and methods for adaptive routing in mobile ad-hoc networks and disruptio2012
Method and system for detecting attack path connections in a computer network us2012
Method and system for aggregating algorithms for detecting linked interactive ne2010
Method and system for integrated computer networking attack attribution2010
Systems and methods for queue management in packet-switched networks2010
Systems and methods for efficient buffering and metering of high-speed flows2009